In the BioHarmony Drug Report Database

"Preview" Icon

Troglitazone

Prelay, Rezulin, Actos, Glustin (troglitazone) is a small molecule pharmaceutical. Troglitazone was first approved as Prelay on 1997-01-29. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus. The pharmaceutical is active against peroxisome proliferator-activated receptor gamma. In addition, it is known to target transient receptor potential cation channel subfamily M member 3.

 

Trade Name

 

Actos, Glustin
 

Common Name

 

troglitazone
 

ChEMBL ID

 

CHEMBL408
 

Indication

 

type 2 diabetes mellitus
 

Drug Class

 

Ppst agonists (thiazolidene derivatives)

Image (chem structure or protein)

Troglitazone structure rendering